- Home
- FSHP vs GNLX Comparison
FSHP vs GNLX Comparison
Compare FSHP & GNLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FSHP
- GNLX
- Stock Information
- Founded
- FSHP 2018
- GNLX 2001
- Country
- FSHP United States
- GNLX United States
- Employees
- FSHP N/A
- GNLX N/A
- Industry
- FSHP
- GNLX Biotechnology: Pharmaceutical Preparations
- Sector
- FSHP
- GNLX Health Care
- Exchange
- FSHP NYSE
- GNLX Nasdaq
- Market Cap
- FSHP 92.2M
- GNLX 112.8M
- IPO Year
- FSHP 2024
- GNLX 2023
- Fundamental
- Price
- FSHP N/A
- GNLX $3.09
- Analyst Decision
- FSHP
- GNLX Strong Buy
- Analyst Count
- FSHP 0
- GNLX 4
- Target Price
- FSHP N/A
- GNLX $17.75
- AVG Volume (30 Days)
- FSHP 754.0
- GNLX 137.5K
- Earning Date
- FSHP 01-01-0001
- GNLX 08-13-2025
- Dividend Yield
- FSHP N/A
- GNLX N/A
- EPS Growth
- FSHP N/A
- GNLX N/A
- EPS
- FSHP 0.21
- GNLX N/A
- Revenue
- FSHP N/A
- GNLX N/A
- Revenue This Year
- FSHP N/A
- GNLX N/A
- Revenue Next Year
- FSHP N/A
- GNLX N/A
- P/E Ratio
- FSHP $49.03
- GNLX N/A
- Revenue Growth
- FSHP N/A
- GNLX N/A
- 52 Week Low
- FSHP $9.99
- GNLX $1.60
- 52 Week High
- FSHP $10.48
- GNLX $5.89
- Technical
- Relative Strength Index (RSI)
- FSHP N/A
- GNLX 56.10
- Support Level
- FSHP N/A
- GNLX $2.75
- Resistance Level
- FSHP N/A
- GNLX $3.17
- Average True Range (ATR)
- FSHP 0.00
- GNLX 0.24
- MACD
- FSHP 0.00
- GNLX -0.00
- Stochastic Oscillator
- FSHP 0.00
- GNLX 56.94
About FSHP FLAG SHIP ACQUISITION CORPORATION
Flag Ship Acquisition Corp is a blank check company formed to effect a merger, share exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses.
About GNLX Genelux Corporation
Genelux Corp is a clinical-stage biopharmaceutical company. The company focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive or difficult-to-treat solid tumor types. Its pipeline products include Olvi-Vec (olvimulogene nanivacirepvec), Lung, and Pancreatic Cancer.